Dara Biosciences, Inc. (DARA) Reports Q2 Loss of 24c/Share

Dara Biosciences, Inc. (NASDAQ: DARA) reported Q2 EPS of ($0.24), $0.27 better than last year. Revenue for the quarter came in at $409.4 thousand.

For earnings history and earnings-related data on Dara Biosciences, Inc. (DARA) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Owlet (OWLT) Tops Q2 EPS by 9c
• RideNow Group, Inc. (RDNW) Tops Q2 EPS by 4c